Catherine D. Shubkin, MD

The choice to pursue gynecologic oncology has been driven by my professional passion to provide excellent, evidence-based and compassionate patient care. I strive to be a kind, reliable and positive member of our gynecological oncology team in order to best meet the needs of our community. The nature of gynecological oncology care is rewarding in that I’m able to embrace the aspect of continuity of care with each and every patient, forming and building the relationship between physician and patient, gaining their trust and guiding them from diagnosis, through treatment, and onward through their medical journey.

As a board-certified rheumatologist who sees both adult and pediatric patients, I have a broad range of expertise in rheumatic diseases, including lupus, vasculitis, gout and rheumatoid arthritis. My research interests are similarly broad and primarily concern epidemiology and health services research through my appointment in the Dartmouth Institute for Health Policy and Clinical Practice. I spend a lot of time with each patient so that I can fully understand why they’ve come to see me. I take my patients’ problems seriously and never dismiss their issues. I use the information I gather through testing, examination, and discussion to offer options for treatment that will best address the patient’s condition and meet their goals. I enjoy the intellectual challenge of rheumatology and I like working with people. Working directly with patients is the most rewarding aspect of my job.

Vascular disease can affect every aspect of a patient’s life. Its complexity means proper treatment requires a comprehensive plan. That's why I listen carefully to my patients so I can understand their concerns. I explain care options in detail so that with their help, I can tailor each plan to their unique needs. I’m able to walk my patients through that process and provide the best care possible thanks to the full gamut of therapies available at Dartmouth Health. Ultimately, my goal is to help my patients tackle this complicated disease. The sooner they get back to the activities they love, the better.